BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gordon MY, Levicar N, Pai M, Bachellier P, Dimarakis I, Al-Allaf F, M’Hamdi H, Thalji T, Welsh JP, Marley SB. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells. 2006;24:1822-1830. [PMID: 16556705 DOI: 10.1634/stemcells.2005-0629] [Cited by in Crossref: 195] [Cited by in F6Publishing: 176] [Article Influence: 12.2] [Reference Citation Analysis]
Number Citing Articles
1 Yanagawa T, Sumiyoshi H, Higashi K, Nakao S, Higashiyama R, Fukumitsu H, Minakawa K, Chiba Y, Suzuki Y, Sumida K, Saito K, Kamiya A, Inagaki Y. Identification of a Novel Bone Marrow Cell-Derived Accelerator of Fibrotic Liver Regeneration Through Mobilization of Hepatic Progenitor Cells in Mice. Stem Cells 2019;37:89-101. [PMID: 30270488 DOI: 10.1002/stem.2916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
2 Sanal MG. Personalized Medicine in Cell Therapy and Transplantation. In: Barh D, Dhawan D, Ganguly NK, editors. Omics for Personalized Medicine. New Delhi: Springer India; 2013. pp. 775-99. [DOI: 10.1007/978-81-322-1184-6_33] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Kim C, Schneider G, Abdel-Latif A, Mierzejewska K, Sunkara M, Borkowska S, Ratajczak J, Morris AJ, Kucia M, Ratajczak MZ. Ceramide-1-phosphate regulates migration of multipotent stromal cells and endothelial progenitor cells--implications for tissue regeneration. Stem Cells 2013;31:500-10. [PMID: 23193025 DOI: 10.1002/stem.1291] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 8.9] [Reference Citation Analysis]
4 Logan GJ, de Alencastro G, Alexander IE, Yeoh GC. Exploiting the unique regenerative capacity of the liver to underpin cell and gene therapy strategies for genetic and acquired liver disease. Int J Biochem Cell Biol 2014;56:141-52. [PMID: 25449261 DOI: 10.1016/j.biocel.2014.10.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Chernykh ER, Starostina NM, Paltsev AI, Leplina OY, Shevela EY, Shipunov MV, Selihova YB, Kulagin AD, Lisukov IA, Nikonov SD, Ostanin AA, Kozlov VA. Autologous bone marrow cells in the treatment of cirrhosis of the liver. Bull Exp Biol Med 2007;144:640-5. [DOI: 10.1007/s10517-007-0393-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
6 Feng X, Pai M, Mizandari M, Chikovani T, Spalding D, Jiao L, Habib N. Towards the optimization of management of hepatocellular carcinoma. Front Med 2011;5:271-6. [DOI: 10.1007/s11684-011-0148-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Mukhopadhyay A. Perspective on liver regeneration by bone marrow-derived stem cells-a scientific realization or a paradox. Cytotherapy 2013;15:881-92. [PMID: 23623692 DOI: 10.1016/j.jcyt.2013.02.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
8 Lorenzini S, Gitto S, Grandini E, Andreone P, Bernardi M. Stem cells for end stage liver disease: How far have we got? World J Gastroenterol 2008; 14(29): 4593-4599 [PMID: 18698672 DOI: 10.3748/wjg.14.4593] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
9 Wang PP, Xie DY, Liang XJ, Peng L, Zhang GL, Ye YN, Xie C, Gao ZL. HGF and direct mesenchymal stem cells contact synergize to inhibit hepatic stellate cells activation through TLR4/NF-kB pathway. PLoS One. 2012;7:e43408. [PMID: 22927965 DOI: 10.1371/journal.pone.0043408] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
10 Reza HA, Okabe R, Takebe T. Organoid transplant approaches for the liver. Transpl Int 2021;34:2031-45. [PMID: 34614263 DOI: 10.1111/tri.14128] [Reference Citation Analysis]
11 Al Tayeb H, El Dorry A, Amer N, Mowafy N, Zimaity M, Bayoumy E, Saleh SA. Autologous Stem Cells Transplantation in Egyptian Patients with Liver Cirrhosis on Top of Hepatitis C Virus. Int J Stem Cells 2015;8:209-18. [PMID: 26634069 DOI: 10.15283/ijsc.2015.8.2.209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
12 Krishna KA, Krishna KS, Berrocal R, Tummala A, Rao KS, Rao KR. A review on the therapeutic potential of embryonic and induced pluripotent stem cells in hepatic repair. J Nat Sci Biol Med 2011;2:141-4. [PMID: 22346225 DOI: 10.4103/0976-9668.92314] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
13 Huang MT, Cao YL, Feng ZM, Ji DJ, Zhang WH, Shi XY, Wang P, Tang M, Tan H, Xie YX, Zhao RT. TIPS combined with autologous bone marrow stem cell transplantation for treatment of decompensated liver cirrhosis. Shijie Huaren Xiaohua Zazhi 2013; 21(30): 3275-3280 [DOI: 10.11569/wcjd.v21.i30.3275] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Di Campli C, Zocco M, Saulnier N, Grieco A, Rapaccini G, Addolorato G, Rumi C, Santoliquido A, Leone G, Gasbarrini G, Gasbarrini A. Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure. Digestive and Liver Disease 2007;39:1071-6. [DOI: 10.1016/j.dld.2007.08.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
15 Meng YC, Jiang HX, Zhang JH. Clinical applications of bone marrow stem cells to treat liver diseases: recent progress. Shijie Huaren Xiaohua Zazhi 2011; 19(27): 2846-2851 [DOI: 10.11569/wcjd.v19.i27.2846] [Reference Citation Analysis]
16 Lemoli RM, Catani L, Talarico S, Loggi E, Gramenzi A, Baccarani U, Fogli M, Grazi GL, Aluigi M, Marzocchi G. Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. Stem Cells. 2006;24:2817-2825. [PMID: 16931769 DOI: 10.1634/stemcells.2006-0333] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 4.1] [Reference Citation Analysis]
17 Porada CD, Atala AJ, Almeida-Porada G. The hematopoietic system in the context of regenerative medicine. Methods. 2016;99:44-61. [PMID: 26319943 DOI: 10.1016/j.ymeth.2015.08.015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
18 Sharma M, Kulkarni A, Sasikala M, Kumar P, Jaggaiahgari S, Pondugala K, Jaishetwar G, Darisetty S, Jagtap N, Gupta R, Singh JR, Fatima S, Rao PN, Rao GV, Reddy DN. Long-term Outcome of Autologous Hematopoietic Stem Cell Infusion in Cirrhosis: Waning Effect over Time. J Clin Transl Hepatol 2020;8:385-90. [PMID: 33447521 DOI: 10.14218/JCTH.2020.00052] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Terai S, Tanimoto H, Maeda M, Zaitsu J, Hisanaga T, Iwamoto T, Fujisawa K, Mizunaga Y, Matsumoto T, Urata Y. Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy. J Gastroenterol. 2012;47:491-497. [PMID: 22488349 DOI: 10.1007/s00535-012-0580-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
20 Tsolaki E, Athanasiou E, Gounari E, Zogas N, Siotou E, Yiangou M, Anagnostopoulos A, Yannaki E. Hematopoietic stem cells and liver regeneration: differentially acting hematopoietic stem cell mobilization agents reverse induced chronic liver injury. Blood Cells Mol Dis. 2014;53:124-132. [PMID: 24923531 DOI: 10.1016/j.bcmd.2014.05.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
21 Almeida-Porada G, Zanjani ED, Porada CD. Bone marrow stem cells and liver regeneration. Exp Hematol 2010;38:574-80. [PMID: 20417684 DOI: 10.1016/j.exphem.2010.04.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.8] [Reference Citation Analysis]
22 Saito T, Okumoto K, Haga H, Nishise Y, Ishii R, Sato C, Watanabe H, Okada A, Ikeda M, Togashi H. Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev. 2011;20:1503-1510. [PMID: 21417817 DOI: 10.1089/scd.2011.0074] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
23 Álvarez-mercado AI, García-mediavilla MV, Sánchez-campos S, Abadía F, Sáez-lara MJ, Cabello-donayre M, Gil Á, González-gallego J, Fontana L. Deleterious Effect of Human Umbilical Cord Blood Mononuclear Cell Transplantation on Thioacetamide-Induced Chronic Liver Damage in Rats. Cell Transplant 2009;18:1069-79. [DOI: 10.3727/096368909x12483162197088] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Kuroda Y, Dezawa M. Mesenchymal stem cells and their subpopulation, pluripotent muse cells, in basic research and regenerative medicine. Anat Rec (Hoboken). 2014;297:98-110. [PMID: 24293378 DOI: 10.1002/ar.22798] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
25 Sakaida I. Autologous bone marrow cell infusion therapy for liver cirrhosis. Journal of Gastroenterology and Hepatology 2008;23:1349-53. [DOI: 10.1111/j.1440-1746.2008.05381.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
26 Kisseleva T, Brenner DA. Anti-fibrogenic strategies and the regression of fibrosis. Best Pract Res Clin Gastroenterol. 2011;25:305-317. [PMID: 21497747 DOI: 10.1016/j.bpg.2011.02.011] [Cited by in Crossref: 116] [Cited by in F6Publishing: 120] [Article Influence: 10.5] [Reference Citation Analysis]
27 Bird TG, Lorenzini S, Forbes SJ. Activation of stem cells in hepatic diseases. Cell Tissue Res. 2008;331:283-300. [PMID: 18046579 DOI: 10.1007/s00441-007-0542-z] [Cited by in Crossref: 124] [Cited by in F6Publishing: 118] [Article Influence: 8.3] [Reference Citation Analysis]
28 Hénon P. Key Success Factors for Regenerative Medicine in Acquired Heart Diseases. Stem Cell Rev Rep 2020;16:441-58. [PMID: 32297205 DOI: 10.1007/s12015-020-09961-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
29 Alejandra MR, Juan AB, Ana SR. Cell therapy for liver diseases: current medicine and future promises. Expert Rev Gastroenterol Hepatol 2015;9:837-50. [PMID: 25747732 DOI: 10.1586/17474124.2015.1016913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
30 Ma HC, Shi XL, Ren HZ, Yuan XW, Ding YT. Targeted migration of mesenchymal stem cells modified with CXCR4 to acute failing liver improves liver regeneration. World J Gastroenterol 2014; 20(40): 14884-14894 [PMID: 25356048 DOI: 10.3748/wjg.v20.i40.14884] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
31 Inagaki Y, Higashiyama R. Interplay between bone marrow and liver in the pathogenesis of hepatic fibrosis. Hepatol Res 2012;42:543-8. [PMID: 22409274 DOI: 10.1111/j.1872-034X.2012.00978.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Almaeen A, Wani FA, Thirunavukkarasu A. Knowledge and attitudes towards stem cells and the significance of their medical application among healthcare sciences students of Jouf University. PeerJ 2021;9:e10661. [PMID: 33552720 DOI: 10.7717/peerj.10661] [Reference Citation Analysis]
33 Alison MR, Choong C, Lim S. Application of liver stem cells for cell therapy. Semin Cell Dev Biol 2007;18:819-26. [PMID: 17997335 DOI: 10.1016/j.semcdb.2007.09.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
34 Reebye V, Sætrom P, Mintz PJ, Rossi JJ, Kasahara N, Nteliopoulos G, Nicholls J, Haoudi A, Gordon M, Habib NA. A Short-activating RNA Oligonucleotide Targeting the Islet β-cell Transcriptional Factor MafA in CD34(+) Cells. Mol Ther Nucleic Acids 2013;2:e97. [PMID: 23736775 DOI: 10.1038/mtna.2013.23] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
35 Eom YW, Kim G, Baik SK. Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives. World J Gastroenterol 2015; 21(36): 10253-10261 [PMID: 26420953 DOI: 10.3748/wjg.v21.i36.10253] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
36 Marei NH, El-Sherbiny IM, Lotfy A, El-Badawy A, El-Badri N. Mesenchymal stem cells growth and proliferation enhancement using PLA vs PCL based nanofibrous scaffolds. Int J Biol Macromol 2016;93:9-19. [PMID: 27554939 DOI: 10.1016/j.ijbiomac.2016.08.053] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
37 Ratajczak MZ, Mierzejewska K, Ratajczak J, Kucia M. CD133 Expression Strongly Correlates with the Phenotype of Very Small Embryonic-/Epiblast-Like Stem Cells. Adv Exp Med Biol 2013;777:125-41. [PMID: 23161080 DOI: 10.1007/978-1-4614-5894-4_9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
38 Kallis YN, Alison MR, Forbes SJ. Bone marrow stem cells and liver disease. Gut. 2007;56:716-724. [PMID: 17145739 DOI: 10.1136/gut.2006.098442] [Cited by in Crossref: 109] [Cited by in F6Publishing: 102] [Article Influence: 6.8] [Reference Citation Analysis]
39 Zekri AR, Salama H, Medhat E, Musa S, Abdel-Haleem H, Ahmed OS, Khedr HA, Lotfy MM, Zachariah KS, Bahnassy AA. The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency. Stem Cell Res Ther 2015;6:118. [PMID: 26062731 DOI: 10.1186/s13287-015-0106-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
40 Ratajczak MZ, Kucia M, Ratajczak J, Zuba-surma EK. A multi-instrumental approach to identify and purify very small embryonic like stem cells (VSELs) from adult tissues. Micron 2009;40:386-93. [DOI: 10.1016/j.micron.2008.09.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
41 Si Y, Tsou CL, Croft K, Charo IF. CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. J Clin Invest. 2010;120:1192-1203. [PMID: 20234092 DOI: 10.1172/jci40310] [Cited by in Crossref: 125] [Cited by in F6Publishing: 96] [Article Influence: 10.4] [Reference Citation Analysis]
42 Cui L, Shi Y, Han Y, Fan D. Immunological basis of stem cell therapy in liver diseases. Expert Rev Clin Immunol. 2014;10:1185-1196. [PMID: 24964800 DOI: 10.1586/1744666X.2014.930665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
43 Mintz PJ, Huang KW, Reebye V, Nteliopoulos G, Lai HS, Sætrom P, Kasahara N, Jensen S, Pai M, Gordon MY, Marley SB, Behan R, Spalding DR, Haoudi A, Emara MM, Nicholls J, Rossi JJ, Habib NA. Exploiting human CD34+ stem cell-conditioned medium for tissue repair. Mol Ther 2014;22:149-59. [PMID: 23985698 DOI: 10.1038/mt.2013.194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
44 Stutchfield BM, Forbes SJ, Wigmore SJ. Prospects for stem cell transplantation in the treatment of hepatic disease. Liver Transpl. 2010;16:827-836. [PMID: 20583084 DOI: 10.1002/lt.22083] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
45 Nakamura T, Torimura T, Iwamoto H, Kurogi J, Inoue H, Hori Y, Sumie S, Fukushima N, Sakata M, Koga H. CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis. J Gastroenterol Hepatol. 2014;29:1830-1838. [PMID: 24731186 DOI: 10.1111/jgh.12622] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
46 Kisseleva T, Gigante E, Brenner DA. Recent advances in liver stem cell therapy. Curr Opin Gastroenterol. 2010;26:395-402. [PMID: 20495456 DOI: 10.1097/mog.0b013e32833a6bec] [Cited by in Crossref: 49] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
47 Karegli J, Melchionna T, Farrar CA, Greenlaw R, Smolarek D, Horsfield C, Charif R, Mcvey JH, Dorling A, Sacks SH, Smith RAG. Thrombalexins: Cell-Localized Inhibition of Thrombin and Its Effects in a Model of High-Risk Renal Transplantation. Am J Transplant 2017;17:272-80. [DOI: 10.1111/ajt.13951] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
48 Yan L, Han Y, Wang J, Liu J, He Y, Wang H, Fan D. Peripheral blood monocytes from the decompensated liver cirrhosis could migrate into nude mouse liver with human hepatocyte-markers expression. Biochem Biophys Res Commun. 2008;371:635-638. [PMID: 18435910 DOI: 10.1016/j.bbrc.2008.04.058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
49 Piscaglia AC. Stem cells, a two-edged sword: Risks and potentials of regenerative medicine. World J Gastroenterol 2008; 14(27): 4273-4279 [PMID: 18666313 DOI: 10.3748/wjg.14.4273] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
50 Ellor S, Shupe T, Petersen B. Stem cell therapy for inherited metabolic disorders of the liver. Exp Hematol 2008;36:716-25. [PMID: 18375039 DOI: 10.1016/j.exphem.2008.02.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
51 Spahr L, Chalandon Y, Terraz S, Kindler V, Rubbia-Brandt L, Frossard JL, Breguet R, Lanthier N, Farina A, Passweg J. Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One. 2013;8:e53719. [PMID: 23341981 DOI: 10.1371/journal.pone.0053719] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 7.9] [Reference Citation Analysis]
52 Secunda R, Vennila R, Mohanashankar AM, Rajasundari M, Jeswanth S, Surendran R. Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study. Cytotechnology. 2015;67:793-807. [PMID: 24798808 DOI: 10.1007/s10616-014-9718-z] [Cited by in Crossref: 102] [Cited by in F6Publishing: 100] [Article Influence: 12.8] [Reference Citation Analysis]
53 Lin S, Chang Y, Liu J, Chang L, Sun L, Li Y, Luo G, Liao C, Chen P, Chen T, Lee R, Yang K, Harn H, Chiou T. Transplantation of Human Wharton's Jelly-Derived Stem Cells Alleviates Chemically Induced Liver Fibrosis in Rats. Cell Transplant 2010;19:1451-63. [DOI: 10.3727/096368910x514198] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
54 Salama H, Zekri AR, Zern M, Bahnassy A, Loutfy S, Shalaby S, Vigen C, Burke W, Mostafa M, Medhat E, Alfi O, Huttinger E. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. Cell Transplant. 2010;19:1475-1486. [PMID: 20587151 DOI: 10.3727/096368910x514314] [Cited by in Crossref: 78] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
55 Vainshtein JM, Kabarriti R, Mehta KJ, Roy-Chowdhury J, Guha C. Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2014;89:786-803. [PMID: 24969793 DOI: 10.1016/j.ijrobp.2014.02.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
56 Moore JK, Stutchfield BM, Forbes SJ. Systematic review: the effects of autologous stem cell therapy for patients with liver disease. Aliment Pharmacol Ther. 2014;39:673-685. [PMID: 24528093 DOI: 10.1111/apt.12645] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
57 Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N, Kazemi Ashtiani S, Malekzadeh R, Baharvand H. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 2007; 13(24): 3359-3363 [PMID: 17659676 DOI: 10.3748/wjg.v13.i24.3359] [Cited by in CrossRef: 119] [Cited by in F6Publishing: 104] [Article Influence: 7.9] [Reference Citation Analysis]
58 Wang K, Chen X, Ren J. Autologous bone marrow stem cell transplantation in patients with liver failure: a meta-analytic review. Stem Cells Dev 2015;24:147-59. [PMID: 25356526 DOI: 10.1089/scd.2014.0337] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
59 Huebert RC, Rakela J. Cellular therapy for liver disease. Mayo Clin Proc. 2014;89:414-424. [PMID: 24582199 DOI: 10.1016/j.mayocp.2013.10.023] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
60 Wang J, Zhou X, Cui L, Yan L, Liang J, Cheng X, Qiao L, Shi Y, Han Z, Cao Y. The significance of CD14+ monocytes in peripheral blood stem cells for the treatment of rat liver cirrhosis. Cytotherapy. 2010;12:1022-1034. [PMID: 20849360 DOI: 10.3109/14653249.2010.515578] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
61 Khan S, Khan RS, Newsome PN. Cell Therapy for Liver Disease: From Promise to Reality. Semin Liver Dis 2020;40:411-26. [PMID: 33764490 DOI: 10.1055/s-0040-1717096] [Reference Citation Analysis]
62 Kuroda Y, Kitada M, Wakao S, Dezawa M. Bone marrow mesenchymal cells: how do they contribute to tissue repair and are they really stem cells? Arch Immunol Ther Exp (Warsz). 2011;59:369-378. [PMID: 21789625 DOI: 10.1007/s00005-011-0139-9] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
63 Fitzpatrick E, Mitry RR, Dhawan A. Human hepatocyte transplantation: state of the art. J Intern Med. 2009;266:339-357. [PMID: 19765179 DOI: 10.1111/j.1365-2796.2009.02152.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 88] [Article Influence: 8.1] [Reference Citation Analysis]
64 Kwak KA, Cho HJ, Yang JY, Park YS. Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis. Can J Gastroenterol Hepatol. 2018;2018:4197857. [PMID: 29670867 DOI: 10.1155/2018/4197857] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
65 Esrefoglu M. Role of stem cells in repair of liver injury: Experimental and clinical benefit of transferred stem cells on liver failure. World J Gastroenterol 2013; 19(40): 6757-6773 [PMID: 24187451 DOI: 10.3748/wjg.v19.i40.6757] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
66 Kumar A, Pati NT, Sarin SK. Use of stem cells for liver diseases-current scenario. J Clin Exp Hepatol 2011;1:17-26. [PMID: 25755306 DOI: 10.1016/S0973-6883(11)60114-X] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
67 Guo C, Guo G, Zhou X, Chen Y, Han Z, Yang C, Zhao S, Su H, Lian Z, Leung PSC, Gershwin ME, Zhou X, Han Y. Long-term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation in Patients With Cirrhosis. Clin Gastroenterol Hepatol 2019;17:1175-1182.e2. [PMID: 30613001 DOI: 10.1016/j.cgh.2018.10.034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
68 Shupe T, Petersen BE. Potential applications for cell regulatory factors in liver progenitor cell therapy. Int J Biochem Cell Biol 2011;43:214-21. [PMID: 20851776 DOI: 10.1016/j.biocel.2010.09.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Higashiyama R, Moro T, Nakao S, Mikami K, Fukumitsu H, Ueda Y, Ikeda K, Adachi E, Bou-Gharios G, Okazaki I. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology. 2009;137:1459-1466.e1. [PMID: 19596008 DOI: 10.1053/j.gastro.2009.07.006] [Cited by in Crossref: 83] [Cited by in F6Publishing: 86] [Article Influence: 6.4] [Reference Citation Analysis]
70 Kallis YN, Forbes SJ. The bone marrow and liver fibrosis: friend or foe? Gastroenterology 2009;137:1218-21. [PMID: 19720278 DOI: 10.1053/j.gastro.2009.08.026] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
71 Mikhail MA, M'Hamdi H, Welsh J, Levicar N, Marley SB, Nicholls JP, Habib NA, Louis LS, Fisk NM, Gordon MY. High frequency of fetal cells within a primitive stem cell population in maternal blood. Hum Reprod 2008;23:928-33. [PMID: 18238907 DOI: 10.1093/humrep/dem417] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
72 Vosough M, Moslem M, Pournasr B, Baharvand H. Cell-based therapeutics for liver disorders. Br Med Bull 2011;100:157-72. [PMID: 21771778 DOI: 10.1093/bmb/ldr031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
73 Xu YQ, Liu ZC. Therapeutic potential of adult bone marrow stem cells in liver disease and delivery approaches. Stem Cell Rev. 2008;4:101-112. [PMID: 18481229 DOI: 10.1007/s12015-008-9019-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
74 Jindal A, Jagdish RK, Kumar A. Hepatic Regeneration in Cirrhosis. Journal of Clinical and Experimental Hepatology 2021. [DOI: 10.1016/j.jceh.2021.08.029] [Reference Citation Analysis]
75 Ratajczak MZ, Liu R, Marlicz W, Blogowski W, Starzynska T, Wojakowski W, Zuba-surma E. Identification of Very Small Embryonic/Epiblast-Like Stem Cells (VSELs) Circulating in Peripheral Blood During Organ/Tissue Injuries. Recent Advances in Cytometry, Part B - Advances in Applications. Elsevier; 2011. pp. 31-54. [DOI: 10.1016/b978-0-12-385493-3.00003-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
76 Fattahi F, Asgari S, Pournasr B, Seifinejad A, Totonchi M, Taei A, Aghdami N, Salekdeh GH, Baharvand H. Disease-corrected hepatocyte-like cells from familial hypercholesterolemia-induced pluripotent stem cells. Mol Biotechnol. 2013;54:863-873. [PMID: 23247991 DOI: 10.1007/s12033-012-9635-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
77 Mannheimer EG, Quintanilha LF, Carvalho AB, Paredes BD, Gonçalves de Carvalho F, Takyia CM, Resende CMC, Ferreira da Motta Rezende G, Carlos Campos de Carvalho A, Schanaider A, Coeli dos Santos Goldenberg R. Bone marrow cells obtained from cirrhotic rats do not improve function or reduce fibrosis in a chronic liver disease model: Bone marrow cells obtained from cirrhotic rats. Clinical Transplantation 2011;25:54-60. [DOI: 10.1111/j.1399-0012.2009.01191.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
78 Ratajczak MZ, Shin DM, Liu R, Mierzejewska K, Ratajczak J, Kucia M, Zuba-Surma EK. Very small embryonic/epiblast-like stem cells (VSELs) and their potential role in aging and organ rejuvenation--an update and comparison to other primitive small stem cells isolated from adult tissues. Aging (Albany NY) 2012;4:235-46. [PMID: 22498452 DOI: 10.18632/aging.100449] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
79 Levicar N, Dimarakis I, Flores C, Tracey J, Gordon MY, Habib NA. Stem cells as a treatment for chronic liver disease and diabetes. Handb Exp Pharmacol. 2007;243-262. [PMID: 17554512 DOI: 10.1007/978-3-540-68976-8_11] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
80 Shi X, DeLucia AL, Bao J, Zhang P. Alcohol abuse and disorder of granulopoiesis. Pharmacol Ther 2019;198:206-19. [PMID: 30831129 DOI: 10.1016/j.pharmthera.2019.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
81 Dan YY. Clinical uses of liver stem cells. Methods Mol Biol 2012;826:11-23. [PMID: 22167636 DOI: 10.1007/978-1-61779-468-1_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
82 Haleem AM, Singergy AA, Sabry D, Atta HM, Rashed LA, Chu CR, El Shewy MT, Azzam A, Abdel Aziz MT. The Clinical Use of Human Culture-Expanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects: A Pilot Study and Preliminary Results. Cartilage. 2010;1:253-261. [PMID: 21170288 DOI: 10.1177/1947603510366027] [Cited by in Crossref: 217] [Cited by in F6Publishing: 186] [Article Influence: 18.1] [Reference Citation Analysis]
83 Piscaglia AC, Novi M, Campanale M, Gasbarrini A. Stem cell-based therapy in gastroenterology and hepatology. Minim Invasive Ther Allied Technol. 2008;17:100-118. [PMID: 18465445 DOI: 10.1080/13645700801969980] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
84 King A, Barton D, Beard HA, Than N, Moore J, Corbett C, Thomas J, Guo K, Guha I, Hollyman D, Stocken D, Yap C, Fox R, Forbes SJ, Newsome PN. REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial. BMJ Open 2015;5:e007700. [PMID: 25795699 DOI: 10.1136/bmjopen-2015-007700] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
85 Kim Y, Ozer S, Uygun BE. Liver Regeneration. Regenerative Medicine Applications in Organ Transplantation. Elsevier; 2014. pp. 333-52. [DOI: 10.1016/b978-0-12-398523-1.00024-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Zhang W, Teng M, Liu B, Liu Q, Liu X, Si Y, Li L. Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy. Gastroenterol Res Pract 2018;2018:4136082. [PMID: 30510572 DOI: 10.1155/2018/4136082] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Kawai K, Xue F, Takahara T, Kudo H, Yata Y, Zhang W, Sugiyama T. Matrix metalloproteinase-9 contributes to the mobilization of bone marrow cells in the injured liver. Cell Transplant 2012;21:453-64. [PMID: 22793053 DOI: 10.3727/096368911X605367] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
88 Yu SJ, Yoon JH, Kim W, Lee JM, Lee YB, Cho Y, Lee DH, Lee M, Yoo JJ, Cho EJ, Lee JH, Kim YJ, Kim CY. Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis. Korean J Intern Med 2017;32:261-8. [PMID: 27044856 DOI: 10.3904/kjim.2015.267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
89 Chen LN, Montemayor-Garcia C, West-Mitchell KA, Cantilena CC. Increased serum pro-B-type natriuretic peptide in hematopoietic progenitor cell donors stimulated with G-CSF. J Clin Apher 2022. [PMID: 35301751 DOI: 10.1002/jca.21979] [Reference Citation Analysis]
90 Salama H, Zekri ARN, Bahnassy AA, Medhat E, Halim HA, Ahmed OS, Mohamed G, Alim SAA, Sherif GM. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol 2010; 16(42): 5297-5305 [PMID: 21072892 DOI: 10.3748/wjg.v16.i42.5297] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
91 Couto BG, Goldenberg RC, da Fonseca LM, Thomas J, Gutfilen B, Resende CM, Azevedo F, Mercante DR, Torres AL, Coelho HS. Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study. Liver Int. 2011;31:391-400. [PMID: 21281433 DOI: 10.1111/j.1478-3231.2010.02424.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
92 Tripathi H, Peng H, Donahue R, Chelvarajan L, Gottipati A, Levitan B, Al-Darraji A, Gao E, Abdel-Latif A, Berron BJ. Isolation Methods for Human CD34 Subsets Using Fluorescent and Magnetic Activated Cell Sorting: an In Vivo Comparative Study. Stem Cell Rev Rep 2020;16:413-23. [PMID: 31953639 DOI: 10.1007/s12015-019-09939-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
93 Drosos I, Kolios G. Stem cells in liver regeneration and their potential clinical applications. Stem Cell Rev Rep 2013;9:668-84. [PMID: 23526206 DOI: 10.1007/s12015-013-9437-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
94 Mintz PJ, Sætrom P, Reebye V, Lundbæk MB, Lao K, Rossi JJ, Gaensler KM, Kasahara N, Nicholls JP, Jensen S, Haoudi A, Emara MM, Gordon MY, Habib NA. MicroRNA-181a* Targets Nanog in a Subpopulation of CD34(+) Cells Isolated From Peripheral Blood. Mol Ther Nucleic Acids 2012;1:e34. [PMID: 23344176 DOI: 10.1038/mtna.2012.29] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
95 Pai M, Zacharoulis D, Milicevic MN, Helmy S, Jiao LR, Levicar N, Tait P, Scott M, Marley SB, Jestice K. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol. 2008;103:1952-1958. [PMID: 18637092 DOI: 10.1111/j.1572-0241.2008.01993.x] [Cited by in Crossref: 152] [Cited by in F6Publishing: 131] [Article Influence: 10.9] [Reference Citation Analysis]
96 Salama H, Zekri AR, Medhat E, Al Alim SA, Ahmed OS, Bahnassy AA, Lotfy MM, Ahmed R, Musa S. Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease. Stem Cell Res Ther. 2014;5:70. [PMID: 24886681 DOI: 10.1186/scrt459] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 6.6] [Reference Citation Analysis]
97 Takami T, Terai S, Sakaida I. Stem cell therapy in chronic liver disease. Curr Opin Gastroenterol. 2012;28:203-208. [PMID: 22395569 DOI: 10.1097/mog.0b013e3283521d6a] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
98 Grund N, Maier P, Giordano FA, Appelt JU, Zucknick M, Li L, Wenz F, Zeller WJ, Fruehauf S, Allgayer H, Laufs S. Analysis of self-inactivating lentiviral vector integration sites and flanking gene expression in human peripheral blood progenitor cells after alkylator chemotherapy. Hum Gene Ther 2010;21:943-56. [PMID: 20210626 DOI: 10.1089/hum.2009.116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
99 Pai M, Spalding D, Xi F, Habib N. Autologous bone marrow stem cells in the treatment of chronic liver disease. Int J Hepatol. 2012;2012:307165. [PMID: 22121493 DOI: 10.1155/2012/307165] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
100 Russo FP, N. Kallis Y, Alison MR, Forbes SJ. Bone marrow cells in the liver: Diverse cells, diverse effects. Hepatology 2007;46:604-5. [DOI: 10.1002/hep.21794] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
101 Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, Yokoyama Y, Uchida K, Yamasaki T, Fujii Y, Okita K, Sakaida I. Improved Liver Function in Patients with Liver Cirrhosis After Autologous Bone Marrow Cell Infusion Therapy. Stem Cells 2006;24:2292-8. [DOI: 10.1634/stemcells.2005-0542] [Cited by in Crossref: 344] [Cited by in F6Publishing: 303] [Article Influence: 21.5] [Reference Citation Analysis]
102 Abdelaziz D, Hefnawy A, Al-Wakeel E, El-Fallal A, El-Sherbiny IM. New biodegradable nanoparticles-in-nanofibers based membranes for guided periodontal tissue and bone regeneration with enhanced antibacterial activity. J Adv Res 2021;28:51-62. [PMID: 33364045 DOI: 10.1016/j.jare.2020.06.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
103 Lyra AC, Soares MB, da Silva LF, Braga EL, Oliveira SA, Fortes MF, Silva AG, Brustolim D, Genser B, Dos Santos RR. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: A pilot randomized controlled study. Eur J Gastroenterol Hepatol. 2010;22 Suppl 1:33-42. [PMID: 19654548 DOI: 10.1097/meg.0b013e32832eb69a] [Cited by in Crossref: 74] [Cited by in F6Publishing: 33] [Article Influence: 6.7] [Reference Citation Analysis]
104 Eguchi S, Kanematsu T. What is the real contribution of extrahepatic cells to liver regeneration? Surg Today 2009;39:1-4. [DOI: 10.1007/s00595-008-3836-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
105 Chen ZH, Lv X, Dai H, Liu C, Lou D, Chen R, Zou GM. Hepatic regenerative potential of mouse bone marrow very small embryonic-like stem cells. J Cell Physiol. 2015;230:1852-1861. [PMID: 25545634 DOI: 10.1002/jcp.24913] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
106 Lee JY, Hong SH. Hematopoietic Stem Cells and Their Roles in Tissue Regeneration. Int J Stem Cells 2020;13:1-12. [PMID: 31887851 DOI: 10.15283/ijsc19127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
107 Gennero L, Roos MA, Sperber K, Denysenko T, Bernabei P, Calisti GF, Papotti M, Cappia S, Pagni R, Aimo G. Pluripotent plasticity of stem cells and liver repopulation. Cell Biochem Funct. 2010;28:178-189. [PMID: 20232487 DOI: 10.1002/cbf.1630] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
108 Burra P, Bizzaro D, Ciccocioppo R, Marra F, Piscaglia AC, Porretti L, Gasbarrini A, Russo FP. Therapeutic application of stem cells in gastroenterology: An up-date. World J Gastroenterol 2011; 17(34): 3870-3880 [PMID: 22025875 DOI: 10.3748/wjg.v17.i34.3870] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
109 Ratajczak M, Zuba-surma E, Kucia M, Poniewierska A, Suszynska M, Ratajczak J. Pluripotent and multipotent stem cells in adult tissues. Advances in Medical Sciences 2012;57:1-17. [DOI: 10.2478/v10039-012-0020-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
110 Muraca M. Evolving concepts in cell therapy of liver disease and current clinical perspectives. Dig Liver Dis. 2011;43:180-187. [PMID: 20869923 DOI: 10.1016/j.dld.2010.08.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
111 Sharma M, Rao PN, Sasikala M, Kuncharam MR, Reddy C, Gokak V, Raju B, Singh JR, Nag P, Reddy DN. Autologous mobilized peripheral blood CD34+ cell infusion in non-viral decompensated liver cirrhosis. World J Gastroenterol 2015; 21(23): 7264-7271 [PMID: 26109814 DOI: 10.3748/wjg.v21.i23.7264] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
112 Russo FP, Parola M. Stem and progenitor cells in liver regeneration and repair. Cytotherapy. 2011;13:135-144. [PMID: 21235295 DOI: 10.3109/14653249.2010.545386] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
113 Broering DC, Walter J, Braun F, Rogiers X. Current Status of Hepatic Transplantation. Current Problems in Surgery 2008;45:587-661. [DOI: 10.1067/j.cpsurg.2008.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
114 Al-toma A, Nijeboer P, Bouma G, Visser O, Mulder CJ. Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases. World J Gastroenterol 2014; 20(46): 17368-17375 [PMID: 25516648 DOI: 10.3748/wjg.v20.i46.17368] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
115 Ramos IPR, Dias ML, Nunes De Moraes AC, Meireles Ferreira FG, Souza SAL, Gutfilen B, Barboza T, Ferreira Pimentel C, Paz Batista CM, Kasai-Brunswick TH, Fortes FDSA, De Andrade CBV, Goldenberg RCDS. Granulocyte Colony-Stimulating Factor Treatment Before Radiotherapy Protects Against Radiation-Induced Liver Disease in Mice. Front Pharmacol 2021;12:725084. [PMID: 34867327 DOI: 10.3389/fphar.2021.725084] [Reference Citation Analysis]
116 Jang YO, Jun BG, Baik SK, Kim MY, Kwon SO. Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis. Clin Mol Hepatol. 2015;21:141-149. [PMID: 26157751 DOI: 10.3350/cmh.2015.21.2.141] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
117 Nakamura T, Koga H, Iwamoto H, Tsutsumi V, Imamura Y, Naitou M, Masuda A, Ikezono Y, Abe M, Wada F. Ex vivo expansion of circulating CD34(+) cells enhances the regenerative effect on rat liver cirrhosis. Mol Ther Methods Clin Dev. 2016;3:16025. [PMID: 27162932 DOI: 10.1038/mtm.2016.25] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
118 Nakamura T, Tsutsumi V, Torimura T, Naitou M, Iwamoto H, Masuda H, Hashimoto O, Koga H, Abe M, Ii M, Kawamoto A, Asahara T, Ueno T, Sata M. Human peripheral blood CD34-positive cells enhance therapeutic regeneration of chronically injured liver in nude rats. J Cell Physiol 2012;227:1538-52. [PMID: 21678408 DOI: 10.1002/jcp.22873] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
119 Al-Toma A, Mulder CJ. Review article: Stem cell transplantation for the treatment of gastrointestinal diseases--current applications and future perspectives. Aliment Pharmacol Ther. 2007;26 Suppl 2:77-89. [PMID: 18081652 DOI: 10.1111/j.1365-2036.2007.03478.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
120 Johal KS, Lees VC, Reid AJ. Adipose-derived stem cells: selecting for translational success. Regen Med. 2015;10:79-96. [PMID: 25562354 DOI: 10.2217/rme.14.72] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
121 De Luna-Saldivar MM, Marino-Martinez IA, Franco-Molina MA, Rivera-Morales LG, Alarcón-Galván G, Cordero-Pérez P, Rojas-Martínez A, Rodríguez-Padilla C, Muñoz-Espinosa LE. Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats. Ann Hepatol 2019;18:620-6. [PMID: 31147180 DOI: 10.1016/j.aohep.2018.12.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
122 Amin MA, Sabry D, Rashed LA, Aref WM, el-Ghobary MA, Farhan MS, Fouad HA, Youssef YA. Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study. Clin Transplant. 2013;27:607-612. [PMID: 23923970 DOI: 10.1111/ctr.12179] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
123 Lorenzini S, Isidori A, Catani L, Gramenzi A, Talarico S, Bonifazi F, Giudice V, Conte R, Baccarani M, Bernardi M. Stem cell mobilization and collection in patients with liver cirrhosis. Aliment Pharmacol Ther. 2008;27:932-939. [PMID: 18315586 DOI: 10.1111/j.1365-2036.2008.03670.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
124 Hénon P, Kowalczyk M, Aries A, Vignon C, Trébuchet G, Lahlil R. Industrialized GMP Production of CD34+ Cells (ProtheraCytes®) at Clinical Scale for Treatment of Ischemic Cardiac Diseases Is Feasible and Safe. Stem Cell Rev Rep 2022. [PMID: 35420389 DOI: 10.1007/s12015-022-10373-5] [Reference Citation Analysis]
125 Sasikala M, Surya P, Radhika G, Kumar PP, Rao MS, Mukherjee RM, Rao PN, Reddy DN. Identification of circulating CD90+ CD73+ cells in cirrhosis of liver. World J Stem Cells 2011; 3(7): 63-69 [PMID: 21860671 DOI: 10.4252/wjsc.v3.i7.63] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
126 Salama H, Zekri AR, Ahmed R, Medhat I, Abdallah ES, Darwish T, Ahmed OS, Bahnassy A. Assessment of health-related quality of life in patients receiving stem cell therapy for end-stage liver disease: an Egyptian study. Stem Cell Res Ther. 2012;3:49. [PMID: 23206927 DOI: 10.1186/scrt140] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
127 Tao YC, Chen EQ. Clinical application of stem cell in patients with end-stage liver disease: progress and challenges. Ann Transl Med 2020;8:564. [PMID: 32775365 DOI: 10.21037/atm.2020.03.153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
128 Lorenzini S, Andreone P. Stem cell therapy for human liver cirrhosis: a cautious analysis of the results. Stem Cells. 2007;25:2383-2384. [PMID: 17540855 DOI: 10.1634/stemcells.2007-0056] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
129 Fagoonee S, Famulari ES, Silengo L, Camussi G, Altruda F. Prospects for Adult Stem Cells in the Treatment of Liver Diseases. Stem Cells Dev. 2016; Epub ahead of print. [PMID: 27503633 DOI: 10.1089/scd.2016.0144] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
130 Ryu KH. Liver stem cells derived from the bone marrow and umbilical cord blood. Int J Stem Cells 2009;2:97-101. [PMID: 24855527 DOI: 10.15283/ijsc.2009.2.2.97] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
131 Weberpals JI, Koti M, Squire JA. Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer. Cancer Genetics 2011;204:525-35. [DOI: 10.1016/j.cancergen.2011.09.004] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
132 Stutchfield BM, Rashid S, Forbes SJ, Wigmore SJ. Practical Barriers to Delivering Autologous Bone Marrow Stem Cell Therapy as an Adjunct to Liver Resection. Stem Cells and Development 2010;19:155-62. [DOI: 10.1089/scd.2009.0412] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
133 Saito T, Tomita K, Haga H, Okumoto K, Ueno Y. Bone marrow cell-based regenerative therapy for liver cirrhosis. World J Methodol 2013; 3(4): 65-69 [PMID: 25237624 DOI: 10.5662/wjm.v3.i4.65] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
134 Herr I, Groth A, Schemmer P, Büchler MW. Adult stem cells in progression and therapy of hepatocellular carcinoma. Int J Cancer 2007;121:1875-82. [DOI: 10.1002/ijc.23041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
135 Kisseleva T, Brenner DA. The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis. J Hepatol 2012;56:965-72. [PMID: 22173163 DOI: 10.1016/j.jhep.2011.09.021] [Cited by in Crossref: 62] [Cited by in F6Publishing: 61] [Article Influence: 5.6] [Reference Citation Analysis]
136 Souza BS, Nogueira RC, de Oliveira SA, de Freitas LA, Lyra LG, Ribeiro dos Santos R, Lyra AC, Soares MB. Current status of stem cell therapy for liver diseases. Cell Transplant. 2009;18:1261-1279. [PMID: 19660179 DOI: 10.3727/096368909x470522] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
137 Burra P, Tomat S, Villa E, Gasbarrini A, Costa AN, Conconi MT, Forbes SJ, Farinati F, Cozzi E, Alison MR. Experimental hepatology applied to stem cells. Dig Liver Dis. 2008;40:54-61. [PMID: 17997371 DOI: 10.1016/j.dld.2007.08.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
138 Russo FP, Parola M. Stem cells in liver failure. Best Pract Res Clin Gastroenterol. 2012;26:35-45. [PMID: 22482524 DOI: 10.1016/j.bpg.2012.01.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
139 Fleischmann G. Symposium in Stem Cell Repair and Regeneration. Cloning and Stem Cells 2007;9:141-3. [DOI: 10.1089/clo.2006.0075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
140 Gordon MY. Stem cells for regenerative medicine—Biological attributes and clinical application. Experimental Hematology 2008;36:726-32. [DOI: 10.1016/j.exphem.2008.01.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
141 Dan YY, Yeoh GC. Liver stem cells: a scientific and clinical perspective. J Gastroenterol Hepatol. 2008;23:687-698. [PMID: 18410603 DOI: 10.1111/j.1440-1746.2008.05383.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 3.9] [Reference Citation Analysis]
142 Leeb C, Jurga M, Mcguckin C, Moriggl R, Kenner L. Promising New Sources for Pluripotent Stem Cells. Stem Cell Rev and Rep 2010;6:15-26. [DOI: 10.1007/s12015-009-9102-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
143 Strom SC, Jorns C. Cell Therapy of Liver Disease. Principles of Regenerative Medicine. Elsevier; 2019. pp. 229-46. [DOI: 10.1016/b978-0-12-809880-6.00016-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
144 Saucourt C, Vogt S, Merlin A, Valat C, Criquet A, Harmand L, Birebent B, Rouard H, Himmelspach C, Jeandidier É, Chartois-Leauté AG, Derenne S, Koehl L, Salem JE, Hulot JS, Tancredi C, Aries A, Judé S, Martel E, Richard S, Douay L, Hénon P. Design and Validation of an Automated Process for the Expansion of Peripheral Blood-Derived CD34+ Cells for Clinical Use After Myocardial Infarction. Stem Cells Transl Med 2019;8:822-32. [PMID: 31037857 DOI: 10.1002/sctm.17-0277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
145 Behbahan IS, Keating A, Gale RP. Concise review: bone marrow autotransplants for liver disease? Stem Cells 2013;31:2313-29. [PMID: 23939914 DOI: 10.1002/stem.1510] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
146 Mohamadnejad M, Vosough M, Moossavi S, Nikfam S, Mardpour S, Akhlaghpoor S, Ashrafi M, Azimian V, Jarughi N, Hosseini SE, Moeininia F, Bagheri M, Sharafkhah M, Aghdami N, Malekzadeh R, Baharvand H. Intraportal Infusion of Bone Marrow Mononuclear or CD133+ Cells in Patients With Decompensated Cirrhosis: A Double-Blind Randomized Controlled Trial. Stem Cells Transl Med 2016;5:87-94. [PMID: 26659833 DOI: 10.5966/sctm.2015-0004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
147 Huang M, Feng Z, Ji D, Cao Y, Shi X, Chen P, Wang P, Tang M, Liu K. Use of a transjugular intrahepatic portosystemic shunt combined with autologous bone marrow cell infusion in patients with decompensated liver cirrhosis: an exploratory study. Cytotherapy. 2014;16:1575-1583. [PMID: 25287603 DOI: 10.1016/j.jcyt.2014.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
148 Rathi S, Hussaini T, Yoshida EM. Granulocyte colony stimulating factor: A potential therapeutic rescue in severe alcoholic hepatitis and decompensated cirrhosis. Ann Hepatol 2021;20:100211. [PMID: 32533952 DOI: 10.1016/j.aohep.2020.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Lyra AC, Soares MBP, Silva LFMD, Fortes MF, Silva AGP, Mota ACA, Oliveira SA, Braga EL, Carvalho WA, Genser B, Santos RRD, Lyra LGC. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 2007; 13(7): 1067-1073 [PMID: 17373741 DOI: 10.3748/wjg.v13.i7.1067] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 69] [Article Influence: 6.1] [Reference Citation Analysis]
150 Cantz T, Manns MP, Ott M. Stem cells in liver regeneration and therapy. Cell Tissue Res. 2008;331:271-282. [PMID: 17901986 DOI: 10.1007/s00441-007-0483-6] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
151 Shiota G, Itaba N. Progress in stem cell-based therapy for liver disease. Hepatol Res. 2017;47:127-141. [PMID: 27188253 DOI: 10.1111/hepr.12747] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
152 Khan AA, Parveen N, Mahaboob VS, Rajendraprasad A, Ravindraprakash HR, Venkateswarlu J, Rao SG, Narusu ML, Khaja MN, Pramila R. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study. Transplant Proc. 2008;40:1140-1144. [PMID: 18555134 DOI: 10.1016/j.transproceed.2008.03.111] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
153 Abdel Aziz MT, El Asmar M, Mostafa S, Salama H, Atta HM, Mahfouz S, Roshdy NK, Rashed LA, Sabry D, Hasan N, Mahmoud M, Elderwy D. Reversal of Hepatic Fibrosis by Human CD34(+) Stem/Progenitor Cell Transplantation in Rats. Int J Stem Cells 2010;3:161-74. [PMID: 24855554 DOI: 10.15283/ijsc.2010.3.2.161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
154 Tsolaki E, Yannaki E. Stem cell-based regenerative opportunities for the liver: State of the art and beyond. World J Gastroenterol 2015; 21(43): 12334-12350 [PMID: 26604641 DOI: 10.3748/wjg.v21.i43.12334] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
155 Pasquet S, Sovalat H, Hénon P, Bischoff N, Arkam Y, Ojeda-Uribe M, Bouar Rl, Rimelen V, Brink I, Dallemand R, Monassier JP. Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct. Cytotherapy 2009;11:1002-15. [PMID: 19929464 DOI: 10.3109/14653240903164963] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
156 Allameh A, Kazemnejad S. Safety evaluation of stem cells used for clinical cell therapy in chronic liver diseases; with emphasize on biochemical markers. Clin Biochem 2012;45:385-96. [PMID: 22306885 DOI: 10.1016/j.clinbiochem.2012.01.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
157 Levicar N, Pai M, Habib NA, Tait P, Jiao LR, Marley SB, Davis J, Dazzi F, Smadja C, Jensen SL. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif. 2008;41 Suppl 1:115-125. [PMID: 18181952 DOI: 10.1111/j.1365-2184.2008.00491.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 49] [Article Influence: 2.6] [Reference Citation Analysis]
158 Han Y, Yan L, Han G, Zhou X, Hong L, Yin Z, Zhang X, Wang S, Wang J, Sun A. Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy. Cytotherapy. 2008;10:390-396. [PMID: 18574771 DOI: 10.1080/14653240802129901] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
159 Zhu B, You S, Rong Y, Yu Q, Lv S, Song F, Liu H, Wang H, Zhao J, Li D, Liu W, Xin S. A novel stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure. Braz J Med Biol Res 2020;53:e9728. [PMID: 33053116 DOI: 10.1590/1414-431X20209728] [Reference Citation Analysis]
160 Mohamadnejad M, Alimoghaddam K, Bagheri M, Ashrafi M, Abdollahzadeh L, Akhlaghpoor S, Bashtar M, Ghavamzadeh A, Malekzadeh R. Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis. Liver Int. 2013;33:1490-1496. [PMID: 23763455 DOI: 10.1111/liv.12228] [Cited by in Crossref: 58] [Cited by in F6Publishing: 67] [Article Influence: 6.4] [Reference Citation Analysis]
161 Al-toma A, Nijeboer P, Bouma G, Visser O, Mulder CJ. Hematopoietic stem cell transplantation for non-malignant gastrointestinal diseases. World J Gastroenterol 2014;20:17368-75. [PMID: 25516648 DOI: 10.3748/wjg.v20.i46.17368] [Reference Citation Analysis]
162 Kharaziha P, Hellström PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, Telkabadi M, Atashi A, Honardoost M, Zali MR, Soleimani M. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trial: . European Journal of Gastroenterology & Hepatology 2009;21:1199-205. [DOI: 10.1097/meg.0b013e32832a1f6c] [Cited by in Crossref: 279] [Cited by in F6Publishing: 142] [Article Influence: 21.5] [Reference Citation Analysis]
163 Neri T, Bucciantini M, Rosti V, Raimondi S, Relini A, Massa M, Zuccotti M, Donadei S, Stefani M, Redi CA, Merlini G, Stoppini M, Garagna S, Bellotti V. Embryonic stem and haematopoietic progenitor cells resist to Aβ oligomer toxicity and maintain the differentiation potency in culture. Amyloid 2010;17:137-45. [DOI: 10.3109/13506129.2010.530138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
164 Inagaki Y, Higashiyama R, Okazaki I. Treatment strategy for liver fibrosis through recruitment and differentiation of bone marrow stem/progenitor cells. Hepatol Res. 2007;37:991-993. [PMID: 17976135 DOI: 10.1111/j.1872-034x.2007.00267.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
165 Matsumoto T, Takami T, Sakaida I. Cell transplantation as a non-invasive strategy for treating liver fibrosis. Expert Rev Gastroenterol Hepatol 2016;10:639-48. [PMID: 26691057 DOI: 10.1586/17474124.2016.1134313] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
166 Duttenhoefer F, de Freitas RL, Loibl M, Bittermann G, Richards RG, Alini M, Verrier S. Endothelial Progenitor Cell Fraction Contained in Bone Marrow-Derived Mesenchymal Stem Cell Populations Impairs Osteogenic Differentiation. Biomed Res Int 2015;2015:659542. [PMID: 26491682 DOI: 10.1155/2015/659542] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
167 Yang DW, Yao P. Cell transplantation for hepatic disease: current research status. Shijie Huaren Xiaohua Zazhi 2011; 19(16): 1720-1725 [DOI: 10.11569/wcjd.v19.i16.1720] [Reference Citation Analysis]
168 Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl. 2010;16:118-129. [PMID: 20104479 DOI: 10.1002/lt.21965] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
169 Francipane MG, Cervello M, Vizzini GB, Pietrosi G, Montalto G. Management of Liver Failure: From Transplantation to Cell-Based Therapy. Cell Med 2011;2:9-25. [PMID: 26998399 DOI: 10.3727/215517911X575993] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
170 Zhang M, Huang B. The multi-differentiation potential of peripheral blood mononuclear cells. Stem Cell Res Ther. 2012;3:48. [PMID: 23200034 DOI: 10.1186/scrt139] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
171 Kochat V, Baligar P, Maiwall R, Mukhopadhyay A. Bone marrow stem-cell therapy for genetic and chronic liver diseases. Hepatol Int 2014;8:166-78. [DOI: 10.1007/s12072-013-9499-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
172 Houlihan DD, Newsome PN. Critical Review of Clinical Trials of Bone Marrow Stem Cells in Liver Disease. Gastroenterology 2008;135:438-50. [DOI: 10.1053/j.gastro.2008.05.040] [Cited by in Crossref: 137] [Cited by in F6Publishing: 118] [Article Influence: 9.8] [Reference Citation Analysis]
173 Trebol Lopez J, Georgiev Hristov T, García-arranz M, García-olmo D. Stem Cell Therapy for Digestive Tract Diseases: Current State and Future Perspectives. Stem Cells and Development 2011;20:1113-29. [DOI: 10.1089/scd.2010.0277] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
174 Chuthapisith S, Eremin J, El-sheemey M, Eremin O. Breast cancer chemoresistance: Emerging importance of cancer stem cells. Surgical Oncology 2010;19:27-32. [DOI: 10.1016/j.suronc.2009.01.004] [Cited by in Crossref: 109] [Cited by in F6Publishing: 102] [Article Influence: 9.1] [Reference Citation Analysis]
175 Boyon C, Vinatier D. [Fetal microchimerism: self and non-self, finally who are we?]. J Gynecol Obstet Biol Reprod (Paris) 2011;40:387-98. [PMID: 21354718 DOI: 10.1016/j.jgyn.2011.01.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
176 Bae SH. [Clinical application of stem cells in liver diseases]. Korean J Hepatol. 2008;14:309-317. [PMID: 18815454 DOI: 10.3350/kjhep.2008.14.3.309] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
177 Volarevic V, Ljujic B, Stojkovic P, Lukic A, Arsenijevic N, Stojkovic M. Human stem cell research and regenerative medicine--present and future. Br Med Bull. 2011;99:155-168. [PMID: 21669982 DOI: 10.1093/bmb/ldr027] [Cited by in Crossref: 66] [Cited by in F6Publishing: 55] [Article Influence: 6.0] [Reference Citation Analysis]
178 Terai S, Sakaida I. Current status of autologous bone marrow cell infusion therapy for liver cirrhosis patients. Hepatol Res 2008;38 Suppl 1:S72-5. [PMID: 19125956 DOI: 10.1111/j.1872-034X.2008.00430.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
179 Yasen A, Tuxun T, Apaer S, Li W, Maimaitinijiati Y, Wang H, Aisan M, Aji T, Shao Y, Hao W. Fetal liver stem cell transplantation for liver diseases. Regen Med 2019;14:703-14. [PMID: 31393226 DOI: 10.2217/rme-2018-0160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Piscaglia AC, Campanale M, Gasbarrini A, Gasbarrini G. Stem cell-based therapies for liver diseases: state of the art and new perspectives. Stem Cells Int. 2010;2010:259461. [PMID: 21048845 DOI: 10.4061/2010/259461] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
181 Lin WR, Brittan M, Alison MR. The role of bone marrow-derived cells in fibrosis. Cells Tissues Organs 2008;188:178-88. [PMID: 18196924 DOI: 10.1159/000113530] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]